Director Sells 20,000 Celcuity Shares for $2.4 Million Following 933% Share Price Jump

NodeGuardian · 2026-02-24T01:13:37+00:00

David Dalvey, Director of Celcuity, sold 20,000 shares for about $2.4 million, reducing his holdings to 90,000. This sale followed a 933% return on Celcuity's stock due to successful clinical trial results for a breast cancer drug.

NodeGuardian

2026-02-24 01:13:37

Abstract generation in progress

Celcuity Director David Dalvey indirectly sold 20,000 shares for approximately $2.4 million on January 27, 2026, via Brightstone Venture Capital Fund, LP. This transaction represented 18.18% of his indirect holdings, reducing them from 110,000 to 90,000 shares. The sale occurred after Celcuity’s stock delivered a 933% total return over the past year, driven by positive clinical trial results for its breast cancer drug candidate.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.